An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral...
Saved in:
Published in | PloS one Vol. 9; no. 3; p. e91551 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
17.03.2014
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4+ T cells and CD8+ T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8+ T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4+CD25+Foxp3+ Tregs and CD8+ T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3+ T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3+ T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8+ T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity. |
---|---|
AbstractList | CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4+ T cells and CD8+ T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8+ T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4+CD25+Foxp3+ Tregs and CD8+ T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3+ T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3+ T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8+ T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity. CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4+ T cells and CD8+ T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8+ T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4+CD25+Foxp3+ Tregs and CD8+ T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3+ T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3+ T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8+ T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity.CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4+ T cells and CD8+ T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8+ T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4+CD25+Foxp3+ Tregs and CD8+ T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3+ T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3+ T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8+ T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity. CD4.sup.+ CD25.sup.+ Foxp3.sup.+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4.sup.+ T cells and CD8.sup.+ T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8.sup.+ T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4.sup.+ CD25.sup.+ Foxp3.sup.+ Tregs and CD8.sup.+ T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3.sup.+ T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3.sup.+ T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8.sup.+ T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity. CD4 + CD25 + Foxp3 + regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood mononuclear cells (PBMCs) of pancreatic ductal adenocarcinoma (PDA) patients using flow cytometry (FCM), few studies have examined how intratumoral Tregs might contribute to immunosuppression in the tumor microenvironment. Thus, the potential role of intratumoral Tregs in PDA patients remains to be elucidated. In this study, we found that the percentages of Tregs, CD4 + T cells and CD8 + T cells were all increased significantly in tumor tissue compared to control pancreatic tissue, as assessed via FCM, whereas the percentages of these cell types in PBMCs did not differ between PDA patients and healthy volunteers. The percentages of CD8 + T cells in tumors were significantly lower than in PDA patient PBMCs. In addition, the relative numbers of CD4 + CD25 + Foxp3 + Tregs and CD8 + T cells were negatively correlated in the tissue of PDA patients, and the abundance of Tregs was significantly correlated with tumor differentiation. Additionally, Foxp3 + T cells were observed more frequently in juxtatumoral stroma (immediately adjacent to the tumor epithelial cells). Patients showing an increased prevalence of Foxp3 + T cells had a poorer prognosis, which was an independent factor for patient survival. These results suggest that Tregs may promote PDA progression by inhibiting the antitumor immunity of CD8 + T cells at local intratumoral sites. Moreover, a high proportion of Tregs in tumor tissues may reflect suppressed antitumor immunity. |
Audience | Academic |
Author | Tang, Yichen Zhang, Chaobin Lu, Binfeng Xu, Xuejun Guo, Shixiang Tang, Yan Ni, Bing Wang, Huaizhi Tian, Yi |
AuthorAffiliation | 2 Institute of Immunology PLA, Third Military Medical University, Chongqing, China 1 Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China Mie University Graduate School of Medicine, Japan 3 Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, United States of America |
AuthorAffiliation_xml | – name: 1 Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China – name: 3 Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, United States of America – name: Mie University Graduate School of Medicine, Japan – name: 2 Institute of Immunology PLA, Third Military Medical University, Chongqing, China |
Author_xml | – sequence: 1 givenname: Yichen surname: Tang fullname: Tang, Yichen – sequence: 2 givenname: Xuejun surname: Xu fullname: Xu, Xuejun – sequence: 3 givenname: Shixiang surname: Guo fullname: Guo, Shixiang – sequence: 4 givenname: Chaobin surname: Zhang fullname: Zhang, Chaobin – sequence: 5 givenname: Yan surname: Tang fullname: Tang, Yan – sequence: 6 givenname: Yi surname: Tian fullname: Tian, Yi – sequence: 7 givenname: Bing surname: Ni fullname: Ni, Bing – sequence: 8 givenname: Binfeng surname: Lu fullname: Lu, Binfeng – sequence: 9 givenname: Huaizhi surname: Wang fullname: Wang, Huaizhi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24637664$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk11v0zAUhiM0xD7gHyCwhITgosVObCfmAqkqX5UmbRqFW8txnNSVa3e2A-x_8INx2m5qpwmhXCQ5ec57cl6fc5odWWdVlj1HcIyKEr1but5bYcbrFB5DyBAh6FF2gliRj2gOi6O95-PsNIQlhKSoKH2SHeeYFiWl-CT7M7FgZqVXIqgGTOreNsJKBVwL5v3K-dHMttpEL6K2HbhSXW9EdP4GzMFUGRPALICp816lcBL4peMCxIUCl951XoWgnQXCNpt364IOg_Kl2FSMWoKPvYzCgEmjrJPCS23dSjzNHrfCBPVsdz_Lvn_-NJ9-HZ1ffJlNJ-cjSVkeR7WoatrSsiCtVBIpBhHL6xyWNa5p1WCkaE2wpLJVbYsRZjVGhWREYIEbUpbFWfZyq7s2LvCdoYEjAitYsQJViZhticaJJV97vRL-hjuh-SbgfMeFT30YxWtIalIhTEiBMRQta0ooB8uJrATDMGl92FXr65VqpLLJVnMgevjF6gXv3E9eMJLOKk8Cb3YC3l33KkS-0kGmUxBWuX7737SkrBo6e3UPfbi7HdWJ1IC2rUt15SDKJ7isSgoZGajxA1S6GrXSMk1fGhB1mPD2ICExUf2OnehD4LNvV__PXvw4ZF_vsQslTFwEZ_qYhiwcgi_2nb6z-HbsE4C3gPQuBK_aOwRBPmzXrV182C6-266U9v5emtRRDOWTI9r8O_kvFbIr5w |
CitedBy_id | crossref_primary_10_1186_s12979_020_0174_7 crossref_primary_10_1002_jhbp_883 crossref_primary_10_4251_wjgo_v16_i4_1134 crossref_primary_10_1016_j_vetimm_2018_11_008 crossref_primary_10_1158_1078_0432_CCR_23_0258 crossref_primary_10_3390_cancers12082274 crossref_primary_10_3389_fimmu_2022_903564 crossref_primary_10_1016_j_pan_2016_09_007 crossref_primary_10_1136_jitc_2020_000764 crossref_primary_10_1158_2159_8290_CD_19_0094 crossref_primary_10_1097_MD_0000000000037797 crossref_primary_10_1007_s12640_015_9563_7 crossref_primary_10_18632_oncotarget_12772 crossref_primary_10_1016_j_canlet_2017_01_041 crossref_primary_10_1016_j_jcyt_2020_08_001 crossref_primary_10_3389_fgene_2021_702102 crossref_primary_10_1080_2162402X_2015_1102828 crossref_primary_10_1049_syb2_12056 crossref_primary_10_1007_s13277_014_2362_6 crossref_primary_10_1053_j_seminoncol_2021_02_007 crossref_primary_10_1158_1078_0432_CCR_18_0900 crossref_primary_10_3390_cancers12102756 crossref_primary_10_1186_s12935_016_0334_1 crossref_primary_10_3389_fcell_2021_660969 crossref_primary_10_1159_000486581 crossref_primary_10_3389_fimmu_2018_00883 crossref_primary_10_1158_1078_0432_CCR_18_1038 crossref_primary_10_3390_curroncol28060371 crossref_primary_10_1080_2162402X_2022_2066767 crossref_primary_10_1016_j_canlet_2015_11_049 crossref_primary_10_1189_jlb_5VMR1116_493R crossref_primary_10_1158_2159_8290_CD_19_0958 crossref_primary_10_1016_j_smim_2017_09_002 crossref_primary_10_1080_2162402X_2018_1541535 crossref_primary_10_1016_j_canlet_2022_215694 crossref_primary_10_1371_journal_pone_0106741 crossref_primary_10_3889_oamjms_2021_7639 crossref_primary_10_33160_yam_2019_03_017 crossref_primary_10_3389_fimmu_2017_00829 crossref_primary_10_1007_s00262_015_1775_4 crossref_primary_10_1007_s00106_019_00758_3 crossref_primary_10_1038_onc_2016_458 crossref_primary_10_1038_s41423_021_00742_4 crossref_primary_10_1007_s00428_018_2297_1 crossref_primary_10_3390_cancers13205086 crossref_primary_10_1016_j_bbrc_2015_03_036 crossref_primary_10_3390_cells9020309 crossref_primary_10_3390_curroncol31080316 crossref_primary_10_1042_BSR20192724 crossref_primary_10_1172_jci_insight_152761 crossref_primary_10_1097_PAP_0000000000000161 crossref_primary_10_1158_0008_5472_CAN_22_2589 crossref_primary_10_1186_s12885_021_08770_z crossref_primary_10_3389_fimmu_2024_1323198 crossref_primary_10_1007_s00277_018_3534_z crossref_primary_10_3390_cancers13246206 crossref_primary_10_1155_2023_8776892 crossref_primary_10_1186_s12957_021_02420_1 crossref_primary_10_1186_s13046_019_1153_8 crossref_primary_10_3390_cancers14061580 crossref_primary_10_3390_biomedicines9060653 crossref_primary_10_1007_s00268_018_4527_8 crossref_primary_10_1186_s12943_020_01151_3 crossref_primary_10_3390_cancers11010039 crossref_primary_10_3389_fphar_2020_586599 crossref_primary_10_3390_vaccines4030028 crossref_primary_10_3389_fendo_2022_1081585 crossref_primary_10_1111_php_13153 crossref_primary_10_1517_14712598_2015_1000298 crossref_primary_10_3389_fimmu_2022_892543 crossref_primary_10_1136_jitc_2020_000960 crossref_primary_10_3390_cancers14163862 crossref_primary_10_1007_s12032_014_0070_0 crossref_primary_10_1016_j_tranon_2020_100965 crossref_primary_10_1038_s41698_024_00681_z crossref_primary_10_1016_j_ctarc_2023_100699 crossref_primary_10_3390_cancers11010002 crossref_primary_10_3748_wjg_v21_i31_9297 crossref_primary_10_18632_aging_102917 crossref_primary_10_1080_10408363_2020_1729692 crossref_primary_10_1155_2017_5458178 crossref_primary_10_1155_2017_7979637 crossref_primary_10_3389_fonc_2021_682217 crossref_primary_10_3389_fimmu_2022_876291 crossref_primary_10_62347_CHXD6134 crossref_primary_10_1186_s12943_018_0858_1 crossref_primary_10_1002_JLB_5MR0717_275RR crossref_primary_10_1016_j_ccell_2022_05_006 crossref_primary_10_1186_s12885_017_3859_3 crossref_primary_10_1155_2019_5981054 crossref_primary_10_1016_j_intimp_2023_109722 crossref_primary_10_18632_oncotarget_20863 crossref_primary_10_3389_fimmu_2017_01900 crossref_primary_10_1007_s00535_023_02020_8 crossref_primary_10_3389_fonc_2020_593452 crossref_primary_10_1038_s41598_019_43992_z crossref_primary_10_20517_cdr_2023_47 crossref_primary_10_1016_j_celrep_2017_06_062 crossref_primary_10_1007_s00595_018_1728_6 crossref_primary_10_3389_fonc_2019_01359 crossref_primary_10_2217_imt_15_73 crossref_primary_10_1146_annurev_physiol_020518_114515 crossref_primary_10_1186_s13045_022_01322_3 crossref_primary_10_1016_j_ejca_2020_03_013 crossref_primary_10_1016_j_biocel_2016_03_009 crossref_primary_10_1016_j_molmed_2017_03_003 crossref_primary_10_1038_onc_2016_90 crossref_primary_10_3390_cancers13246188 crossref_primary_10_1038_s41568_022_00530_w crossref_primary_10_1177_11795549241271691 crossref_primary_10_1038_s41423_018_0004_4 crossref_primary_10_3389_fonc_2024_1325575 crossref_primary_10_1136_jitc_2020_001071 crossref_primary_10_1155_2022_8909631 crossref_primary_10_3390_ijms222111378 crossref_primary_10_1038_s41416_022_01927_y crossref_primary_10_1097_MD_0000000000002266 crossref_primary_10_1186_s12967_016_0812_1 crossref_primary_10_1007_s00428_019_02549_1 crossref_primary_10_1158_1078_0432_CCR_22_1630 crossref_primary_10_1080_2162402X_2016_1175794 crossref_primary_10_1080_21645515_2021_2003645 crossref_primary_10_1016_j_clinbiochem_2016_04_008 crossref_primary_10_1158_2326_6066_CIR_16_0045 crossref_primary_10_3389_fonc_2019_00056 crossref_primary_10_1126_sciadv_adk1827 crossref_primary_10_3390_cancers14040995 crossref_primary_10_1016_j_semcancer_2017_12_009 crossref_primary_10_3390_cancers13194932 crossref_primary_10_18632_oncotarget_2948 crossref_primary_10_3389_fphar_2022_939542 crossref_primary_10_3390_ijms23010254 crossref_primary_10_7717_peerj_8811 crossref_primary_10_1158_0008_5472_CAN_20_2133 crossref_primary_10_2147_RRU_S284066 crossref_primary_10_1097_MD_0000000000005541 crossref_primary_10_1002_cam4_2895 crossref_primary_10_3390_genes12010033 crossref_primary_10_3389_fimmu_2023_1222719 crossref_primary_10_1021_acs_jmedchem_0c00988 crossref_primary_10_1080_2162402X_2025_2451444 crossref_primary_10_2217_imt_2022_0046 crossref_primary_10_3389_fmed_2021_735585 crossref_primary_10_1016_j_molimm_2017_04_012 crossref_primary_10_1016_j_jff_2019_05_006 crossref_primary_10_1073_pnas_1810580115 crossref_primary_10_1007_s00595_019_01817_6 crossref_primary_10_1016_j_oraloncology_2017_02_023 crossref_primary_10_1080_08830185_2017_1363199 crossref_primary_10_3390_cancers14174265 |
Cites_doi | 10.1016/S0039-6060(97)90264-6 10.1016/S0065-2776(06)90002-9 10.1007/s00005-010-0075-0 10.1002/ijc.27784 10.1182/blood-2007-06-094615 10.1084/jem.188.2.287 10.1371/journal.pone.0000129 10.1038/nrgastro.2009.177 10.1038/ni.1774 10.1158/1078-0432.CCR-06-0369 10.1007/s10147-010-0130-1 10.1016/S0065-230X(10)07003-X 10.1136/gutjnl-2011-300970 10.1111/j.1349-7006.2009.01153.x 10.1097/MPA.0b013e3182373a66 10.4049/jimmunol.169.5.2756 10.1038/sj.bjc.6605078 10.1002/ijc.25429 10.1038/bjc.2013.32 10.1371/journal.pone.0080063 10.1158/1078-0432.CCR-06-2363 10.4049/jimmunol.174.5.2591 10.1038/nm1093 10.1038/nri2916 10.1002/ijc.28309 10.1158/1078-0432.CCR-06-2139 10.1084/jem.20102131 10.1002/hep.26013 10.1038/nri1806 10.1007/978-1-59745-409-4_9 10.1007/s00262-008-0603-5 10.1172/JCI31202 10.1111/j.0105-2896.2009.00884.x 10.1182/blood-2004-06-2410 10.3892/etm.2012.553 10.1172/JCI25947 10.1053/j.gastro.2013.07.025 10.1084/jem.20071190 10.1158/0008-5472.CAN-11-0367 10.1159/000342801 10.1084/jem.20042167 10.1158/0008-5472.CAN-07-0175 10.1158/0008-5472.CAN-08-2360 10.1158/1078-0432.CCR-07-5126 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2014 Public Library of Science 2014 Tang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2014 Tang et al 2014 Tang et al |
Copyright_xml | – notice: COPYRIGHT 2014 Public Library of Science – notice: 2014 Tang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2014 Tang et al 2014 Tang et al |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0091551 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ (Directory of Open Access Journals) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Agricultural Science Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
DocumentTitleAlternate | Treg Cells Predict the Prognosis of PDA |
EISSN | 1932-6203 |
ExternalDocumentID | 1508089318 oai_doaj_org_article_b05b5814553440af9d70c00535c8a940 PMC3956642 3248502601 A478760958 24637664 10_1371_journal_pone_0091551 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: NCATS NIH HHS grantid: UL1 TR000005 |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM BBORY CGR CUY CVF ECM EIF IPNFZ NPM PV9 RIG RZL PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 5PM PUEGO - 02 AAPBV ABPTK ADACO BBAFP KM |
ID | FETCH-LOGICAL-c692t-ba8b6f6735fcec1e90192b207b4b68d41e6b54c6cfeff4149b413c95a4a4d5773 |
IEDL.DBID | M48 |
ISSN | 1932-6203 |
IngestDate | Fri Nov 26 17:22:24 EST 2021 Wed Aug 27 01:30:14 EDT 2025 Thu Aug 21 13:53:54 EDT 2025 Thu Jul 10 23:23:33 EDT 2025 Fri Jul 25 10:19:11 EDT 2025 Tue Jun 17 20:59:35 EDT 2025 Tue Jun 10 20:24:23 EDT 2025 Fri Jun 27 04:18:14 EDT 2025 Fri Jun 27 04:10:13 EDT 2025 Thu May 22 21:19:23 EDT 2025 Thu Apr 03 07:00:51 EDT 2025 Tue Jul 01 02:57:34 EDT 2025 Thu Apr 24 23:04:12 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c692t-ba8b6f6735fcec1e90192b207b4b68d41e6b54c6cfeff4149b413c95a4a4d5773 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. Conceived and designed the experiments: HW BN Yichen Tang BL. Performed the experiments: Yichen Tang XX SG CZ Yan Tang Yi Tian. Analyzed the data: Yichen Tang HW BN BL. Contributed reagents/materials/analysis tools: Yichen Tang XX SG Yan Tang. Wrote the paper: Yichen Tang HW BN BL. |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0091551 |
PMID | 24637664 |
PQID | 1508089318 |
PQPubID | 1436336 |
PageCount | e91551 |
ParticipantIDs | plos_journals_1508089318 doaj_primary_oai_doaj_org_article_b05b5814553440af9d70c00535c8a940 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3956642 proquest_miscellaneous_1508676987 proquest_journals_1508089318 gale_infotracmisc_A478760958 gale_infotracacademiconefile_A478760958 gale_incontextgauss_ISR_A478760958 gale_incontextgauss_IOV_A478760958 gale_healthsolutions_A478760958 pubmed_primary_24637664 crossref_primary_10_1371_journal_pone_0091551 crossref_citationtrail_10_1371_journal_pone_0091551 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-03-17 |
PublicationDateYYYYMMDD | 2014-03-17 |
PublicationDate_xml | – month: 03 year: 2014 text: 2014-03-17 day: 17 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2014 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | UK Liyanage (ref39) 2002; 169 DJ Campbell (ref9) 2011; 11 T Yamamoto (ref30) 2012; 41 N Kobayashi (ref10) 2007; 13 YC Lin (ref32) 2013; 132 J Dannull (ref44) 2005; 115 CG Drake (ref8) 2006; 90 ME Lutsiak (ref47) 2005; 105 A Ene-Obong (ref7) 2013; 145 D Mougiakakos (ref16) 2010; 107 TJ Curiel (ref13) 2007; 117 AM Ercolini (ref46) 2005; 201 X Zhou (ref41) 2009; 10 H Ueno (ref3) 2010; 234 CC Preston (ref6) 2013; 8 G Betts (ref22) 2012; 61 S Raimondi (ref1) 2009; 6 KL Ling (ref35) 2007; 7 B Vizio (ref29) 2012; 4 A Pedroza-Gonzalez (ref25) 2011; 208 H Nishikawa (ref17) 2010; 127 B Cambien (ref18) 2009; 100 C Loddenkemper (ref33) 2009; 100 SA Siddiqui (ref20) 2007; 13 R Okita (ref36) 2005; 14 SI Labidi-Galy (ref26) 2011; 71 AM Thornton (ref42) 1998; 188 LC de Rezende (ref43) 2010; 58 DP Kelsen (ref2) 1997; 122 MT Litzinger (ref45) 2007; 110 C Bergmann (ref15) 2008; 14 N Hiraoka (ref27) 2006; 12 Y Ino (ref28) 2013; 108 PA Antony (ref11) 2005; 174 YL Pang (ref23) 2009; 58 CE Clark (ref31) 2007; 67 F Ichihara (ref38) 2003; 9 X Huang (ref14) 2009; 506 Y Huang (ref40) 2012; 86 N Hiraoka (ref4) 2010; 15 A Pedroza-Gonzalez (ref34) 2013; 57 RA Clark (ref19) 2008; 205 TJ Curiel (ref37) 2004; 10 W Zou (ref12) 2006; 6 PJ de Vos van Steenwijk (ref5) 2013; 133 SL Clarke (ref21) 2006; 1 M Gobert (ref24) 2009; 69 20193020 - Immunol Rev. 2010 Mar;234(1):199-212 23891972 - Gastroenterology. 2013 Nov;145(5):1121-32 14555512 - Clin Cancer Res. 2003 Oct 1;9(12):4404-8 15883172 - J Exp Med. 2005 May 16;201(10):1591-602 22907255 - Int J Cancer. 2013 Mar 15;132(6):1341-50 22911397 - Hepatology. 2013 Jan;57(1):183-94 20373146 - Arch Immunol Ther Exp (Warsz). 2010 Jun;58(3):179-90 24244610 - PLoS One. 2013;8(11):e80063 15728465 - J Immunol. 2005 Mar 1;174(5):2591-601 17289884 - Clin Cancer Res. 2007 Feb 1;13(3):902-11 15591121 - Blood. 2005 Apr 1;105(7):2862-8 16211295 - Oncol Rep. 2005 Nov;14(5):1269-73 19244125 - Cancer Res. 2009 Mar 1;69(5):2000-9 18941744 - Cancer Immunol Immunother. 2009 Jun;58(6):877-86 17404089 - Clin Cancer Res. 2007 Apr 1;13(7):2075-81 17388261 - Cancer Immun. 2007;7:7 16730261 - Adv Immunol. 2006;90:51-81 19436305 - Br J Cancer. 2009 Jun 2;100(11):1755-64 23385730 - Br J Cancer. 2013 Mar 5;108(4):914-23 18559587 - Clin Cancer Res. 2008 Jun 15;14(12):3706-15 17616639 - Blood. 2007 Nov 1;110(9):3192-201 19633673 - Nat Immunol. 2009 Sep;10(9):1000-7 20399961 - Adv Cancer Res. 2010;107:57-117 20924634 - Int J Clin Oncol. 2010 Dec;15(6):544-51 17000676 - Clin Cancer Res. 2006 Sep 15;12(18):5423-34 17205133 - PLoS One. 2006;1:e129 22207629 - Gut. 2012 Aug;61(8):1163-71 12193750 - J Immunol. 2002 Sep 1;169(5):2756-61 19806144 - Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):699-708 18794336 - J Exp Med. 2008 Sep 29;205(10):2221-34 20518016 - Int J Cancer. 2010 Aug 15;127(4):759-67 15322536 - Nat Med. 2004 Sep;10(9):942-9 23060925 - Exp Ther Med. 2012 Jul;4(1):70-78 9225915 - Surgery. 1997 Jul;122(1):53-9 17909062 - Cancer Res. 2007 Oct 1;67(19):9518-27 19110623 - Methods Mol Biol. 2009;506:115-26 17476346 - J Clin Invest. 2007 May;117(5):1167-74 21697280 - Cancer Res. 2011 Aug 15;71(16):5423-34 16557261 - Nat Rev Immunol. 2006 Apr;6(4):295-307 21339324 - J Exp Med. 2011 Mar 14;208(3):479-90 23207161 - Digestion. 2012;86(4):329-37 22158072 - Pancreas. 2012 Apr;41(3):409-15 21267013 - Nat Rev Immunol. 2011 Feb;11(2):119-30 9670041 - J Exp Med. 1998 Jul 20;188(2):287-96 23740735 - Int J Cancer. 2013 Dec 15;133(12):2884-94 16308572 - J Clin Invest. 2005 Dec;115(12):3623-33 19514119 - Cancer Sci. 2009 Jun;100(6):1112-7 |
References_xml | – volume: 122 start-page: 53 year: 1997 ident: ref2 article-title: Pain as a predictor of outcome in patients with operable pancreatic carcinoma publication-title: Surgery doi: 10.1016/S0039-6060(97)90264-6 – volume: 90 start-page: 51 year: 2006 ident: ref8 article-title: Mechanisms of immune evasion by tumors publication-title: Adv Immunol doi: 10.1016/S0065-2776(06)90002-9 – volume: 58 start-page: 179 year: 2010 ident: ref43 article-title: Regulatory T cell as a target for cancer therapy publication-title: Arch Immunol Ther Exp (Warsz) doi: 10.1007/s00005-010-0075-0 – volume: 132 start-page: 1341 year: 2013 ident: ref32 article-title: Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer publication-title: Int J Cancer doi: 10.1002/ijc.27784 – volume: 110 start-page: 3192 year: 2007 ident: ref45 article-title: IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity publication-title: Blood doi: 10.1182/blood-2007-06-094615 – volume: 188 start-page: 287 year: 1998 ident: ref42 article-title: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production publication-title: J Exp Med doi: 10.1084/jem.188.2.287 – volume: 1 start-page: e129 year: 2006 ident: ref21 article-title: CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer publication-title: PLoS One doi: 10.1371/journal.pone.0000129 – volume: 6 start-page: 699 year: 2009 ident: ref1 article-title: Epidemiology of pancreatic cancer: an overview publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2009.177 – volume: 10 start-page: 1000 year: 2009 ident: ref41 article-title: Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo publication-title: Nat Immunol doi: 10.1038/ni.1774 – volume: 12 start-page: 5423 year: 2006 ident: ref27 article-title: Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-0369 – volume: 15 start-page: 544 year: 2010 ident: ref4 article-title: Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology publication-title: Int J Clin Oncol doi: 10.1007/s10147-010-0130-1 – volume: 107 start-page: 57 year: 2010 ident: ref16 article-title: Regulatory T cells in cancer publication-title: Adv Cancer Res doi: 10.1016/S0065-230X(10)07003-X – volume: 61 start-page: 1163 year: 2012 ident: ref22 article-title: Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer publication-title: Gut doi: 10.1136/gutjnl-2011-300970 – volume: 100 start-page: 1112 year: 2009 ident: ref33 article-title: Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2009.01153.x – volume: 41 start-page: 409 year: 2012 ident: ref30 article-title: Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer publication-title: Pancreas doi: 10.1097/MPA.0b013e3182373a66 – volume: 7 start-page: 7 year: 2007 ident: ref35 article-title: Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients publication-title: Cancer Immun – volume: 169 start-page: 2756 year: 2002 ident: ref39 article-title: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma publication-title: J Immunol doi: 10.4049/jimmunol.169.5.2756 – volume: 100 start-page: 1755 year: 2009 ident: ref18 article-title: Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605078 – volume: 9 start-page: 4404 year: 2003 ident: ref38 article-title: Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers publication-title: Clin Cancer Res – volume: 127 start-page: 759 year: 2010 ident: ref17 article-title: Regulatory T cells in tumor immunity publication-title: Int J Cancer doi: 10.1002/ijc.25429 – volume: 108 start-page: 914 year: 2013 ident: ref28 article-title: Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer publication-title: Br J Cancer doi: 10.1038/bjc.2013.32 – volume: 14 start-page: 1269 year: 2005 ident: ref36 article-title: CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer publication-title: Oncol Rep – volume: 8 start-page: e80063 year: 2013 ident: ref6 article-title: The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(−) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer publication-title: PLoS One doi: 10.1371/journal.pone.0080063 – volume: 13 start-page: 902 year: 2007 ident: ref10 article-title: FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-2363 – volume: 174 start-page: 2591 year: 2005 ident: ref11 article-title: CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells publication-title: J Immunol doi: 10.4049/jimmunol.174.5.2591 – volume: 10 start-page: 942 year: 2004 ident: ref37 article-title: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival publication-title: Nat Med doi: 10.1038/nm1093 – volume: 11 start-page: 119 year: 2011 ident: ref9 article-title: Phenotypical and functional specialization of FOXP3+ regulatory T cells publication-title: Nat Rev Immunol doi: 10.1038/nri2916 – volume: 133 start-page: 2884 year: 2013 ident: ref5 article-title: Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma publication-title: Int J Cancer doi: 10.1002/ijc.28309 – volume: 13 start-page: 2075 year: 2007 ident: ref20 article-title: Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-2139 – volume: 208 start-page: 479 year: 2011 ident: ref25 article-title: Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation publication-title: J Exp Med doi: 10.1084/jem.20102131 – volume: 57 start-page: 183 year: 2013 ident: ref34 article-title: Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer publication-title: Hepatology doi: 10.1002/hep.26013 – volume: 6 start-page: 295 year: 2006 ident: ref12 article-title: Regulatory T cells, tumour immunity and immunotherapy publication-title: Nat Rev Immunol doi: 10.1038/nri1806 – volume: 506 start-page: 115 year: 2009 ident: ref14 article-title: DNA transposons for modification of human primary T lymphocytes publication-title: Methods Mol Biol doi: 10.1007/978-1-59745-409-4_9 – volume: 58 start-page: 877 year: 2009 ident: ref23 article-title: The immunosuppressive tumor microenvironment in hepatocellular carcinoma publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-008-0603-5 – volume: 117 start-page: 1167 year: 2007 ident: ref13 article-title: Tregs and rethinking cancer immunotherapy publication-title: J Clin Invest doi: 10.1172/JCI31202 – volume: 234 start-page: 199 year: 2010 ident: ref3 article-title: Harnessing human dendritic cell subsets for medicine publication-title: Immunol Rev doi: 10.1111/j.0105-2896.2009.00884.x – volume: 105 start-page: 2862 year: 2005 ident: ref47 article-title: Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide publication-title: Blood doi: 10.1182/blood-2004-06-2410 – volume: 4 start-page: 70 year: 2012 ident: ref29 article-title: Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome publication-title: Exp Ther Med doi: 10.3892/etm.2012.553 – volume: 115 start-page: 3623 year: 2005 ident: ref44 article-title: Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells publication-title: J Clin Invest doi: 10.1172/JCI25947 – volume: 145 start-page: 1121 year: 2013 ident: ref7 article-title: Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.07.025 – volume: 205 start-page: 2221 year: 2008 ident: ref19 article-title: Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells publication-title: J Exp Med doi: 10.1084/jem.20071190 – volume: 71 start-page: 5423 year: 2011 ident: ref26 article-title: Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-11-0367 – volume: 86 start-page: 329 year: 2012 ident: ref40 article-title: Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients publication-title: Digestion doi: 10.1159/000342801 – volume: 201 start-page: 1591 year: 2005 ident: ref46 article-title: Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response publication-title: J Exp Med doi: 10.1084/jem.20042167 – volume: 67 start-page: 9518 year: 2007 ident: ref31 article-title: Dynamics of the immune reaction to pancreatic cancer from inception to invasion publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-0175 – volume: 69 start-page: 2000 year: 2009 ident: ref24 article-title: Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-2360 – volume: 14 start-page: 3706 year: 2008 ident: ref15 article-title: T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-5126 – reference: 23740735 - Int J Cancer. 2013 Dec 15;133(12):2884-94 – reference: 17000676 - Clin Cancer Res. 2006 Sep 15;12(18):5423-34 – reference: 15591121 - Blood. 2005 Apr 1;105(7):2862-8 – reference: 12193750 - J Immunol. 2002 Sep 1;169(5):2756-61 – reference: 20924634 - Int J Clin Oncol. 2010 Dec;15(6):544-51 – reference: 20518016 - Int J Cancer. 2010 Aug 15;127(4):759-67 – reference: 19436305 - Br J Cancer. 2009 Jun 2;100(11):1755-64 – reference: 23207161 - Digestion. 2012;86(4):329-37 – reference: 16211295 - Oncol Rep. 2005 Nov;14(5):1269-73 – reference: 14555512 - Clin Cancer Res. 2003 Oct 1;9(12):4404-8 – reference: 24244610 - PLoS One. 2013;8(11):e80063 – reference: 19806144 - Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):699-708 – reference: 22158072 - Pancreas. 2012 Apr;41(3):409-15 – reference: 22911397 - Hepatology. 2013 Jan;57(1):183-94 – reference: 18794336 - J Exp Med. 2008 Sep 29;205(10):2221-34 – reference: 19110623 - Methods Mol Biol. 2009;506:115-26 – reference: 17404089 - Clin Cancer Res. 2007 Apr 1;13(7):2075-81 – reference: 9670041 - J Exp Med. 1998 Jul 20;188(2):287-96 – reference: 20193020 - Immunol Rev. 2010 Mar;234(1):199-212 – reference: 17289884 - Clin Cancer Res. 2007 Feb 1;13(3):902-11 – reference: 21267013 - Nat Rev Immunol. 2011 Feb;11(2):119-30 – reference: 15883172 - J Exp Med. 2005 May 16;201(10):1591-602 – reference: 22207629 - Gut. 2012 Aug;61(8):1163-71 – reference: 22907255 - Int J Cancer. 2013 Mar 15;132(6):1341-50 – reference: 16308572 - J Clin Invest. 2005 Dec;115(12):3623-33 – reference: 23891972 - Gastroenterology. 2013 Nov;145(5):1121-32 – reference: 17388261 - Cancer Immun. 2007;7:7 – reference: 18941744 - Cancer Immunol Immunother. 2009 Jun;58(6):877-86 – reference: 23060925 - Exp Ther Med. 2012 Jul;4(1):70-78 – reference: 21697280 - Cancer Res. 2011 Aug 15;71(16):5423-34 – reference: 19633673 - Nat Immunol. 2009 Sep;10(9):1000-7 – reference: 16730261 - Adv Immunol. 2006;90:51-81 – reference: 17476346 - J Clin Invest. 2007 May;117(5):1167-74 – reference: 23385730 - Br J Cancer. 2013 Mar 5;108(4):914-23 – reference: 17909062 - Cancer Res. 2007 Oct 1;67(19):9518-27 – reference: 17205133 - PLoS One. 2006;1:e129 – reference: 16557261 - Nat Rev Immunol. 2006 Apr;6(4):295-307 – reference: 20373146 - Arch Immunol Ther Exp (Warsz). 2010 Jun;58(3):179-90 – reference: 15728465 - J Immunol. 2005 Mar 1;174(5):2591-601 – reference: 21339324 - J Exp Med. 2011 Mar 14;208(3):479-90 – reference: 19244125 - Cancer Res. 2009 Mar 1;69(5):2000-9 – reference: 15322536 - Nat Med. 2004 Sep;10(9):942-9 – reference: 18559587 - Clin Cancer Res. 2008 Jun 15;14(12):3706-15 – reference: 19514119 - Cancer Sci. 2009 Jun;100(6):1112-7 – reference: 20399961 - Adv Cancer Res. 2010;107:57-117 – reference: 9225915 - Surgery. 1997 Jul;122(1):53-9 – reference: 17616639 - Blood. 2007 Nov 1;110(9):3192-201 |
SSID | ssj0053866 |
Score | 2.5247567 |
Snippet | CD4+CD25+Foxp3+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood... CD4.sup.+ CD25.sup.+ Foxp3.sup.+ regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the... CD4 + CD25 + Foxp3 + regulatory T cells (Tregs) can inhibit cytotoxic responses. Though several studies have analyzed Treg frequency in the peripheral blood... |
SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e91551 |
SubjectTerms | Abundance Adenocarcinoma Adult Aged Antigens Biology and Life Sciences Cancer therapies Carcinoma, Pancreatic Ductal - immunology Carcinoma, Pancreatic Ductal - mortality Carcinoma, Pancreatic Ductal - pathology Case-Control Studies CD25 antigen CD4 antigen CD8 antigen CD8-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - metabolism Colorectal cancer Comparative analysis Correlation Cytokines Cytometry Cytotoxicity Disease Progression Epithelial cells Female Flow cytometry Forkhead Transcription Factors - metabolism Foxp3 protein Hospitals Humans Immunity Immunology Immunophenotyping Immunoregulation Immunosuppression Immunotherapy Leukocytes (mononuclear) Liver cancer Lymphocyte Count Lymphocytes Lymphocytes T Lymphocytes, Tumor-Infiltrating - immunology Lymphocytes, Tumor-Infiltrating - metabolism Male Medical prognosis Medical research Medicine and Health Sciences Middle Aged Neoplasm Grading Neoplasm Metastasis Neoplasm Staging Ovarian cancer Pancreas Pancreatic cancer Pancreatic Neoplasms - immunology Pancreatic Neoplasms - mortality Pancreatic Neoplasms - pathology Patients Peripheral blood mononuclear cells Prognosis Research and Analysis Methods Stroma Studies Surgery T cells T-Lymphocyte Subsets - immunology T-Lymphocyte Subsets - metabolism T-Lymphocytes, Regulatory - immunology T-Lymphocytes, Regulatory - metabolism Tissues Tumor Microenvironment Tumors |
SummonAdditionalLinks | – databaseName: DOAJ (Directory of Open Access Journals) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBAgYhAYe0eTi2c1wQVUECJGhRb5HtOGWlrbPa7B74H_xgZmxv1KBK5cAx8cRKZsbziMffEPJKtCoHt8NT7IuUMpPzVBZapgp0pZTaKum3Cz5_4Sdn7NN5dX6l1RfWhAV44MC4I51VupIIp10ylqmubkVmPCqJkapmPlsHn7dLpoINhlXMeTwoV4r8KMrlcNU7ewhRBcYJE0fk8fpHqzxbLfvhupDz78rJK67o-C65E2NIOg_vvkduWXeP7MVVOtA3EUr67X3ye-7owmFgONiWKo3HPoCG9h3dbC_7dQr6tVh65Fx3QdehL32__kVPKf7RH-hioAb7d8BtmAB_2lKIGKmv6gqIHlS51l-7fgBqmBnsSwhFDUUwWXhTBcYNfObaLFx_qR6Qs-MPp-9P0tiHITW8LjapVlLzjouy6ow1ua0xLNRFJjTTXLYst1xXzHDT2a5jkHJp8IymrhRTrK2EKB-SmQPO7xNaFzLv8lK2RW5Y3RZ1ZnEjUnW6VqXOdELKnVAaE0HKsVfGsvE7bwKSlcDjBkXZRFEmJB2fWgWQjhvo36G8R1qE2PY3QPGaqHjNTYqXkOeoLU04rzoaimaOcEcI4ycT8tJTIMyGwzqeC7Udhubj1x__QPT924TodSTqemCHUfHsBHwTwndNKA8mlGAszGR4H3V7x5WhwXYAGcSsOT650_frh1-Mwzgp1uY5228DDRZKS5GQR2F5jJwtGAcPxllCxGThTFg_HXGLnx7lvITMHZLjx_9DVk_IbQh0GdYO5uKAzDbrrX0KweRGP_N24w9BrHOJ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELagXLggltcGFjAICThkNw_HcU6oFMoWCVgtXbS3yHacUinrlKY98D_4wcwkbiBoBRxjT6xkxvOwPf6GkGdpIUNwO9zHukg-0yH3RaSEL2GuxEIZKdrjgg8f-fEZe3-enLsNt8alVe5sYmuoi1rjHvkR4pYH4FxD8Wr1zceqUXi66kpoXCXXQvA0mNIlpu92lhh0mXN3XS5OwyMnncNVbc0hxBYYLQzcUYva39vm0aqqm8sCzz_zJ39zSNOb5IaLJOm4E_0euWLsLbLndLWhLxyg9Mvb5MfYUrADmH5uCjpWePkDaGhd0vn2ol77M1suqxY_1y7oaVedvl5_p3M6MVXV0FlDJ1jFA5phANy6pRA30hPM7epwPai0Rfts62bZ4Mgn0nYBqaZvtnqDXwomDjznWi9tfSHvkLPp2_nk2HfVGHzNs2jjKykUL3kaJ6U2OjQZBocqClLFFBcFCw1XCdNcl6YsGSy8FPhHnSWSSVYkaRrfJSMLnN8nNItEWIaxKKJQs6yIssDgcaQsVSZjFSiPxDuh5NpBlWPFjCpvz99SWLJ0PM5RlLkTpUf8_q1VB9XxD_rXKO-eFoG224Z6vcid3uYqSFQiEM09ZiyQZVakgW5BcbSQGQs88hhnS97dWu3NRT5G0CME8xMeedpSINiGxWyehdw2TT779OU_iD6fDoieO6KyBnZo6W5QwD8hiNeA8mBACSZDD7r3cW7vuNLkv5QL3tzN98u7n_TdOChm6FlTbzsaTJcWqUfuderRczZiHPwYZx5JB4ozYP2wxy6_tljnMazfYYl8_--f9YBch0CWYW5gmB6Q0Wa9NQ8hWNyoR61F-AkG_2rv priority: 102 providerName: ProQuest |
Title | An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24637664 https://www.proquest.com/docview/1508089318 https://www.proquest.com/docview/1508676987 https://pubmed.ncbi.nlm.nih.gov/PMC3956642 https://doaj.org/article/b05b5814553440af9d70c00535c8a940 http://dx.doi.org/10.1371/journal.pone.0091551 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELb6uHBBlFcDZTEICThklWwc2zkgtF22tEgtVemi3iLbScpKqbNsdiV64Vfwg5nJSwQVgbhY2nhsZceeVzz-hpAXIlE-mB3uYl0klxmfu3KkpatgrwRSp0pWxwXHJ_xwxj5chBcbpK3Z2jCwvDG0w3pSs2U-_Pb1-i0I_JuqaoPw20HDRWHTIfgM6AVskm2wTQJrGhyz7lwBpJvz5gLdn0YiPDDjIHec9WxVBenfKe6tRV6UN3mlvydX_mKtDu6Q242bScf1vtghG6m9S3YaQS7pqwZt-vU98mNsKSgJzE1PEzrWeDMEaGiR0fP1VbF0j2w2zytwXXtJz-rS9cXymp7TSZrnJT0q6QRLfMBjmAC_61JwKukpJn7VoB9U2aT6bYtyXuLMp8rW3qqh79ZmhW8K-g_M6tLMbXGl7pPZwfR8cug2pRpcw6PRytVKap5xEYSZSY2fRug56pEnNNNcJsxPuQ6Z4SZLs4xBVKbBeJooVEyxJBQieEC2LCzCLqHRSPqZH8hk5BsWJaPIS_GsUmU6UoH2tEOCdlFi0-CYYzmNPK4O5wTEMzWPY1zVuFlVh7jdqEWN4_EX-n1c744WUbirB8XyMm6EOtZeqEOJUO8BY57KokR4pkLMMVJFzHPIU9wtcX2ltdMl8RgRkRDpTzrkeUWBSBwWU30u1bos46OPn_-B6NNZj-hlQ5QVwA6jmusV8J8Q4atHudejBH1iet27uLdbrpQxVgzwwK31cWS732_uftZ146SYvmfTYl3TYC61FA55WItHx9lW2BwieoLTY32_x86_VEDoAQT3ED8_-u-Rj8ktcIAZ5hT6Yo9srZbr9Ak4mSs9IJviQkArJz62B-8HZHt_enJ6Nqg-2wwqvYLt9-lP6x2Ecg |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lc9MwENaUcIALQ3k1UKhgYICDWz9kWT4wTEgpDX3QKSnTm5FkOWQmlUOcDNP_we_gN7LrR8BMB7j0GGutcbTrb1fW7reEPI1S6YHb4Q72RXKY9rgjfCUcCbYSCGWkKI8LDg757gl7fxqerpAfTS0MplU2mFgCdZpr_Ea-hbzlLjhXT7yefnWwaxSerjYtNCqz2DPn32DLVrwabIN-n_n-ztthf9epuwo4msf-3FFSKJ7xKAgzbbRnYgxylO9GiikuUuYZrkKmuc5MljHYQCjAeR2HkkmWhlEUwLxXyFUWgCfHyvSddw3yA3ZwXpfnBZG3VVvD5jS3ZhNiGYxOWu6v7BKw9AWd6SQvLgp0_8zX_M0B7twkN-rIlfYqU1slK8beIqs1NhT0RU1g_fI2-d6zFHAH091NSnsKi01AhuYZHS7O8pkzsNl4UvL12hE9NiNsIZbPzumQ9s1kUtBBQfvYNQQuwwT4qZhCnEqPMJes4hGh0qblb5sX4wJnPpK2CoA13V7oOT4pQCp46pke2_xM3iEnl6Knu6RjYeXXCI194WVeIFLf0yxO_dg1ePwpMxXLQLmqS4JGKYmuqdGxQ8ckKc_7ItgiVWucoCqTWpVd4izvmlbUIP-Qf4P6XsoisXd5IZ-NkhonEuWGKhTIHh8w5sosTiNXlyQ8WsiYuV2ygdaSVFWyS3hKekiyhOSBokuelBJI7mExe2gkF0WRDD58-g-hj8ctoee1UJbDcmhZV2zAf0LSsJbkeksSIEq3htfQtptVKZJfLzPc2dj7xcOPl8M4KWYEWpMvKhlMzxZRl9yrXo_lyvqMg9_krEui1ovTWvr2iB1_KbnVgxj2N8y___fH2iDXdocH-8n-4HDvAbkOQTTDvEQvWied-WxhHkKgOlePSnSg5PNlw9FP9hKocQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKkRAXRPnrQqEGgYBD2vw4tnNAaNlSdSmUqrSot2A7zrLS1lk2u0J9D56Gp2MmyQaCKuDCMfHESsbjb8bx-BtCHotMBeB2uId1kTxmAu7JUEtPga1EUlslq-2Cdwd874S9OY1PV8j35VkYTKtcYmIF1Flh8B_5NvKW--BcA7mdN2kRhzu7L6dfPKwghTuty3IatYns2_OvsHwrXwx3YKyfhOHu6-PBntdUGPAMT8K5p5XUPOciinNjTWATDHh06AvNNJcZCyzXMTPc5DbPGSwmNGC-SWLFFMtiISLo9xK5LCIhcY7JQZteAjjCeXNULxLBdmMZW9PC2S2IazBS6bjCqmJA6xdWp5OivCjo_T138xdnuHudXGuiWNqvzW6NrFh3g6w1OFHSZw2Z9fOb5FvfUcAgTH23Ge1rPHgCMrTI6fHirJh5Q5ePJxV3rxvRIzvCcmLF7Jwe04GdTEo6LOkAK4jAbegAfxtTiFnpIeaV1ZwiVLmsunZFOS6x50Pl6mDY0J2FmeObAryC156ZsSvO1C1y8l_G6TZZdaD5dUKTUAZ5EMksDAxLsjDxLW6FqlwnKtK-7pFoOSipaWjSsVrHJK32_gQsl2odpziUaTOUPeK1T01rmpC_yL_C8W5lkeS7ulHMRmmDGan2Yx1LZJKPGPNVnmTCNxUhj5EqYX6PbKK1pPWJ2Raq0j4SLiGRoOyRR5UEEn04nDIjtSjLdPj-4z8IfTjqCD1thPIC1GFUc3oDvgkJxDqSGx1JgCvTaV5H215qpUx_Tmx4cmnvFzc_bJuxU8wOdLZY1DKYqi1Fj9ypp0er2ZBx8KGc9YjoTJyO6rstbvy54lmPEljrsPDun19rk1wBIErfDg_275GrEE8zTFEMxAZZnc8W9j7ErHP9oAIHSj79bzT6AUKyrHI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Increased+Abundance+of+Tumor-Infiltrating+Regulatory+T+Cells+Is+Correlated+with+the+Progression+and+Prognosis+of+Pancreatic+Ductal+Adenocarcinoma&rft.jtitle=PloS+one&rft.au=Tang%2C+Yichen&rft.au=Xu%2C+Xuejun&rft.au=Guo%2C+Shixiang&rft.au=Zhang%2C+Chaobin&rft.date=2014-03-17&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=9&rft.issue=3&rft_id=info:doi/10.1371%2Fjournal.pone.0091551&rft_id=info%3Apmid%2F24637664&rft.externalDocID=PMC3956642 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |